Clinical observation of Huanxin Decoction in treating liver Depression and fire type insomnia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200067155

Enrollment

Unknown

Registered

2022-12-28

Start date

2023-01-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Test group: Huanxin Decoction

Control group:Esazolam

Eligibility

Sex/Gender

All

Age

18 Years to 200 Years

Inclusion criteria

Inclusion criteria: (1) Both the Western diagnostic criteria for insomnia and the diagnostic criteria for liver depression and fire; (2) At least 18 years old, primary school education or above; (3) The Pittsburgh Sleep Quality Index PSQI > 7; (4) Those who sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the inclusion criteria; (2) there are other obvious symptoms of TCM constitution; (3) Patients with cardiovascular, lung, liver, kidney, hematopoietic system and other serious primary diseases, mental disorders, systemic diseases: pain, cough, fever, surgery, etc.; (4) a woman who is breastfeeding or preparing to become pregnant; (5) Unable to cooperate with the completion of the experiment; (6) Those who do not sign the informed consent.

Design outcomes

Primary

Measure	Time frame
Pittsburgh Sleep Quality Index;	—

Secondary

Measure	Time frame
Self-rating Anxiety Scale;Self-rating Depression Scale;	—

Countries

China

Contacts

Public ContactJialou Li

Foshan Fosun Chancheng Hospital

3329059967@qq.com13380203703

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026